CoraVie Medical is a startup aiming to transform blood pressure monitoring with an implantable continuous blood pressure monitor. Founded in 2020, the company’s device provides real-time data to physicians and patients, improving monitoring and management of high blood pressure. The device can be implanted in a simple office procedure, allowing for continuous monitoring throughout the day. This technology aims to address the limitations of at-home monitoring and create a closed-loop system for treatment similar to continuous glucose monitors. CoraVie is currently seeking FDA approval and raising capital for further development and studies. The company’s goal is to prevent strokes, heart attacks, and other cardiovascular events by improving blood pressure monitoring and management.
Source link